跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOLAK - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TOLAK
Authorized
STANDARD
TOLAK
Hill Dermaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dc4111d61f712ecf
Company
Hill Dermaceuticals Inc
Type
Standard
Approval Details
Approval Id
dc4111d61f712ecf
Drug Approval Canada Name
TOLAK
Product Name
TOLAK
Status
Marketed
Status Date
2019-06-25
Original Market Date
2019-06-25
Din
02485346
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:92.00
Atc Original
L01BC02 FLUOROURACIL
Atc Name
l 01 bc 02
Aig Number
0107505005
Company Name
Hill Dermaceuticals Inc
Company Address
2650 South Mellonville Ave, Sanford, Florida, United States, 32773
Active Ingredients
FLUOROURACIL (FLUOROURACIL SODIUM)
4 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dc4111d61f712ecf
Type
Standard
Back to Health Canada Approvals